Olanzapine 5 Mg ORAL TABLET

DRUG2 trials

Sponsors

Department of Medical Services Ministry of Public Health of Thailand, University of Sao Paulo

Conditions

Complete Response Rate to Chemotherapy-induced Nausea and Vomiting ProphylaxisTinnitusTinnitus, Subjective

Phase 1

Treatment of Tinnitus With Olanzapine

CompletedNCT07190482

University of Sao PauloTinnitus, Tinnitus, Subjective

Start: 2023-10-01End: 2025-01-20Updated: 2026-09-15

Phase 3

Olanzapine for Chemotherapy-induced Nausea and Vomiting Prophylaxis

CompletedNCT04232423

Department of Medical Services Ministry of Public Health of ThailandComplete Response Rate to Chemotherapy-induced Nausea and Vomiting Prophylaxis

Start: 2020-03-01End: 2021-09-30Updated: 2022-01-21